The genomic landscape of schwannoma

Gelareh Zadeh, Kenneth Aldape and colleagues present an integrative genomic analysis of schwannomas. In addition to finding recurrent mutations in ARID1A , ARID1B and DDR1 , they identify a recurrent SH3PXD2A - HTRA1 fusion that confers increased proliferation, invasion and in vivo transformation, a...

Full description

Saved in:
Bibliographic Details
Published inNature genetics Vol. 48; no. 11; pp. 1339 - 1348
Main Authors Agnihotri, Sameer, Jalali, Shahrzad, Wilson, Mark R, Danesh, Arnavaz, Li, Mira, Klironomos, George, Krieger, Jonathan R, Mansouri, Alireza, Khan, Osaama, Mamatjan, Yasin, Landon-Brace, Natalie, Tung, Takyee, Dowar, Mark, Li, Tiantian, Bruce, Jeffrey P, Burrell, Kelly E, Tonge, Peter D, Alamsahebpour, Amir, Krischek, Boris, Agarwalla, Pankaj Kumar, Bi, Wenya Linda, Dunn, Ian F, Beroukhim, Rameen, Fehlings, Michael G, Bril, Vera, Pagnotta, Stefano M, Iavarone, Antonio, Pugh, Trevor J, Aldape, Kenneth D, Zadeh, Gelareh
Format Journal Article
LanguageEnglish
Published New York Nature Publishing Group US 01.11.2016
Nature Publishing Group
Subjects
Online AccessGet full text
ISSN1061-4036
1546-1718
1546-1718
DOI10.1038/ng.3688

Cover

More Information
Summary:Gelareh Zadeh, Kenneth Aldape and colleagues present an integrative genomic analysis of schwannomas. In addition to finding recurrent mutations in ARID1A , ARID1B and DDR1 , they identify a recurrent SH3PXD2A - HTRA1 fusion that confers increased proliferation, invasion and in vivo transformation, and is associated with sensitivity to MEK inhibition. Schwannomas are common peripheral nerve sheath tumors that can cause debilitating morbidities. We performed an integrative analysis to determine genomic aberrations common to sporadic schwannomas. Exome sequence analysis with validation by targeted DNA sequencing of 125 samples uncovered, in addition to expected NF2 disruption, recurrent mutations in ARID1A , ARID1B and DDR1 . RNA sequencing identified a recurrent in-frame SH3PXD2A-HTRA1 fusion in 12/125 (10%) cases, and genomic analysis demonstrated the mechanism as resulting from a balanced 19-Mb chromosomal inversion on chromosome 10q. The fusion was associated with male gender predominance, occurring in one out of every six men with schwannoma. Methylation profiling identified distinct molecular subgroups of schwannomas that were associated with anatomical location. Expression of the SH3PXD2A-HTRA1 fusion resulted in elevated phosphorylated ERK, increased proliferation, increased invasion and in vivo tumorigenesis. Targeting of the MEK-ERK pathway was effective in fusion-positive Schwann cells, suggesting a possible therapeutic approach for this subset of tumors.
Bibliography:SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
ISSN:1061-4036
1546-1718
1546-1718
DOI:10.1038/ng.3688